<DOC>
	<DOCNO>NCT00777933</DOCNO>
	<brief_summary>The use steroid kidney transplantation challenge variable adverse effect may increase patient morbidity mortality . The aim study compare safety efficacy immunosuppressive regimen consist cyclosporine ( CsA ) mycophenolate mofetil ( MMF ) tacrolimus ( TAC ) MMF steroid withdrawal 6 month kidney transplantation low-risk patient .</brief_summary>
	<brief_title>Randomized Trial Cyclosporine Tacrolimus Therapy With Steroid Withdrawal Living-Donor Renal Transplantation</brief_title>
	<detailed_description>131 patient randomize CsA ( n = 63 ) TAC ( n = 68 ) . Of 118 patient biopsy-proven rejection episode serum creatinine level &lt; 2.0 mg/dL 6 month transplantation , 55 CsA group 63 TAC group . We assess patient graft survival , acute rejection episode , adverse event 5 year transplantation .</detailed_description>
	<mesh_term>Tacrolimus</mesh_term>
	<mesh_term>Cyclosporins</mesh_term>
	<mesh_term>Cyclosporine</mesh_term>
	<criteria>old 15 year first live donor kidney transplantation congestive heart failure ( ejection fraction &lt; 35 % ) chronic liver disease underlie diabetes mellitus evidence systemic infection screen time history malignant disease multiple organ transplantation positive serologic evidence human immunodeficiency virus</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2011</verification_date>
</DOC>